136 related articles for article (PubMed ID: 15847221)
1. [Combination effect of pazufloxacin and anti-mrsa drugs against beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)].
Yanagisawa C; Hanaki H; Oishi T; Uehara K; Yamaguchi Y; Matui H; Sunakawa K
Jpn J Antibiot; 2005 Feb; 58(1):11-6. PubMed ID: 15847221
[TBL] [Abstract][Full Text] [Related]
2. [In vitro combination effect of pazufloxacin with various antibiotics against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus].
Maekawa M; Takahashi K; Takahata M; Minami S
Jpn J Antibiot; 2002 Aug; 55(4):440-5. PubMed ID: 12378872
[TBL] [Abstract][Full Text] [Related]
3. [Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa].
Araake M; Hara T; Miyata A; Tani M; Ogawa H
Jpn J Antibiot; 2001 Feb; 54(2):69-78. PubMed ID: 11338680
[TBL] [Abstract][Full Text] [Related]
4. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. II. Synergistic actions of cefotiam with arbekacin and minocycline].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
Jpn J Antibiot; 1993 Feb; 46(2):123-9. PubMed ID: 8331772
[TBL] [Abstract][Full Text] [Related]
5. [Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)].
Hatano K; Yokota Y; Hanaki H; Sunakawa K
Kansenshogaku Zasshi; 2006 May; 80(3):243-50. PubMed ID: 16780131
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
Kouda M; Homma S; Udagawa I; Fukuhara J; Takeuchi M; Tamura K
Jpn J Antibiot; 2000 Mar; 53(3):171-8. PubMed ID: 10834148
[TBL] [Abstract][Full Text] [Related]
7. [Reliability of disc-diffusion susceptibility testing for arbekacin, vancomycin and teicoplanin against methicillin-resistant Staphylococcus aureus].
Kouda M; Homma S; Udagawa I; Tamura K; Fukuhara J; Takeuchi M
Jpn J Antibiot; 1999 Dec; 52(12):681-9. PubMed ID: 10695023
[TBL] [Abstract][Full Text] [Related]
8. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Yamaguchi Y; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Hashimoto T; Yazaki H; Sugahara K; Yanagisawa T; Kawajiri H; Sato S; Ishizaki A; Tachihara-Sato R; Takahashi Y; Ono T; Kageyama Y; Kawaguchi T; Tamura A; Hagane K; Sunakawa K
J Infect Chemother; 2009 Oct; 15(5):274-8. PubMed ID: 19856063
[TBL] [Abstract][Full Text] [Related]
9. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
[TBL] [Abstract][Full Text] [Related]
10. The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin.
Oshiro T; Nagasawa Z; Hanaki H; Ikeda-Dantsuji Y; Nagayama A
J Infect Chemother; 2008 Feb; 14(1):15-22. PubMed ID: 18297444
[TBL] [Abstract][Full Text] [Related]
11. [Attenuation of arbekacin-induced nephrotoxicity in rats by pazufloxacin mesilate].
Kizawa K; Miyazaki M; Nagasawa M; Ogake N; Nagai A; Sanzen T; Kawamura Y
Jpn J Antibiot; 2003 Feb; 56(1):44-54. PubMed ID: 12723398
[TBL] [Abstract][Full Text] [Related]
12. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
13. [Effect of arbekacin on the production of toxic shock syndrome toxin 1 by methicillin-resistant Staphylococcus aureus].
Miyata A; Araake M; Ogawa H; Hanaki H; Hiramatsu K
Jpn J Antibiot; 2001 Jul; 54(7):372-81. PubMed ID: 11560056
[TBL] [Abstract][Full Text] [Related]
14. [Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
Watanabe T; Sobu K; Takase Y; Kawabata T; Kanno M; Yoshida T
Jpn J Antibiot; 1994 Jun; 47(6):701-9. PubMed ID: 8072178
[TBL] [Abstract][Full Text] [Related]
15. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
Ishii T; Takayama Y; Takase Y; Orikasa Y
Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of rapid antimicrobial susceptibility test for Staphylococcus aureus by chemiluminescent assay and its application for screening of beta-lactam antibiotic induced vancomycin-resistant MRSA].
Nagasawa Z; Nakashima Y; Oho M; Kusaba K; Manome I; Nagayama A
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2008; 19(1-2):7-15. PubMed ID: 19583457
[TBL] [Abstract][Full Text] [Related]
17. [Combination effect of teicoplanin and various antibiotics against hetero-VRSA and VRSA].
Hanaki H; Hiramatsu K
Kansenshogaku Zasshi; 1999 Oct; 73(10):1048-53. PubMed ID: 10565121
[TBL] [Abstract][Full Text] [Related]
18. [Vancomycin and arbekacin, drugs of treatment for MRSA infections].
Kobayashi Y
Nihon Rinsho; 1992 May; 50(5):1054-9. PubMed ID: 1507428
[TBL] [Abstract][Full Text] [Related]
19. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology and clinical effect against "beta-lactam antibiotic induced vancoymcin-resistant MRSA (BIVR)"].
Hanaki H
Jpn J Antibiot; 2004 Apr; 57(2):204-12. PubMed ID: 15219058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
